The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized phase II clinical trial of the anti-HER2 (GP2) vaccine to prevent recurrence in high-risk breast cancer patients: A planned interim analysis.
Francois Trappey
No relevant relationships to disclose
John S. Berry
No relevant relationships to disclose
Timothy J Vreeland
No relevant relationships to disclose
Diane F. Hale
No relevant relationships to disclose
Alan K. Sears
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
George Earl Peoples
No relevant relationships to disclose
Elizabeth Ann Mittendorf
No relevant relationships to disclose